Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 2,269,165
- Share change
- +2,269,165
- Total reported value
- $7,508,000
- Price per share
- $3.31
- Number of holders
- 20
- Value change
- +$7,508,000
- Number of buys
- 20
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2022
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
|
Company |
22%
|
9,610,200
|
$7,976,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.9%
|
3,936,640
|
$3,268,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4%
|
1,768,685
|
$1,465,000 | — | 31 Mar 2022 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.3%
|
1,024,000
|
$850,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
788,077
|
$654,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
501,876
|
$417,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.91%
|
401,027
|
$333,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.88%
|
389,952
|
$324,000 | — | 31 Mar 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.69%
|
303,981
|
$252,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
303,218
|
$251,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
129,200
|
$107,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
109,762
|
$91,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.21%
|
91,355
|
$76,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
65,413
|
$54,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
56,292
|
$47,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
55,746
|
$46,000 | — | 31 Mar 2022 | |
| BAILARD, INC. |
13F
|
Company |
0.06%
|
24,400
|
$20,000 | — | 31 Mar 2022 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.05%
|
24,000
|
$20,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
19,705
|
$16,000 | — | 31 Mar 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.04%
|
17,123
|
$14,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
15,506
|
$13,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
14,733
|
$12,000 | — | 31 Mar 2022 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
13,900
|
$12,000 | — | 31 Mar 2022 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$8,000 | — | 31 Mar 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
9,400
|
$7,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,335
|
$4,000 | — | 31 Mar 2022 | |
| TFC Financial Management, Inc. |
13F
|
Company |
0%
|
1,488
|
$1,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
647
|
$1,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
533
|
$442 | — | 31 Mar 2022 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
100
|
$83 | — | 31 Mar 2022 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q2 2022
As of 30 Jun 2022,
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,269,165 shares.
The largest 10 holders included
FEDERATED HERMES, INC., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, SEI INVESTMENTS CO, RENAISSANCE TECHNOLOGIES LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q3 2025 Across Filers
Q3 2025 holders
22
Q2 2022 holders
20
Holder diff
-2
| Investor | Q3 2025 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.